Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Int J Mol Sci ; 22(14)2021 Jul 15.
Article in English | MEDLINE | ID: mdl-34299217

ABSTRACT

The mycobacterial cell wall is composed of large amounts of lipids with varying moieties. Some mycobacteria species hijack host cells and promote lipid droplet accumulation to build the cellular environment essential for their intracellular survival. Thus, lipids are thought to be important for mycobacteria survival as well as for the invasion, parasitization, and proliferation within host cells. However, their physiological roles have not been fully elucidated. Recent studies have revealed that mycobacteria modulate the peroxisome proliferator-activated receptor (PPAR) signaling and utilize host-derived triacylglycerol (TAG) and cholesterol as both nutrient sources and evasion from the host immune system. In this review, we discuss recent findings that describe the activation of PPARs by mycobacterial infections and their role in determining the fate of bacilli by inducing lipid metabolism, anti-inflammatory function, and autophagy.


Subject(s)
Mycobacterium Infections/microbiology , Mycobacterium/metabolism , Peroxisome Proliferator-Activated Receptors/metabolism , Animals , Autophagy/physiology , Cholesterol/metabolism , Humans , Lipid Metabolism , Mycobacterium/growth & development , Mycobacterium/immunology , Mycobacterium Infections/immunology , Mycobacterium Infections/metabolism , Peroxisome Proliferator-Activated Receptors/genetics , Signal Transduction
2.
Indian J Dermatol Venereol Leprol ; 83(3): 298-306, 2017.
Article in English | MEDLINE | ID: mdl-28195079

ABSTRACT

Acne, the most common skin disease, is a disorder of pilosebaceous units that affects adolescents mainly and adults occasionally. The pathogenesis is multifactorial. Besides genetic predisposition, other major factors include the action of androgens, pro-inflammatory lipids acting as ligands of peroxisome proliferator-activated receptors in the sebocytes, toll-like receptor-2 acting on keratinocytes, recognition of pathogen-associated molecular patterns, cytokines, chemokines, inflammasomes, neuroendocrine regulatory mechanisms, diet and other pro-inflammatory targets implicated in the activation of immune detection and response. Most of these factors converge on mammalian target of rapamycin complex1 (mTORC1) activation which is further enhanced by the nutrient signaling of Western diet. This multitude of pathogenic factors has led to a new armamentarium of drugs for the treatment of acne. Topical anti-androgens, insulin-like growth factor-1 inhibitors, peroxisome proliferator-activated receptor-modulators, acetylcholine inhibitors, topical retinoic acid metabolism-blocking agents, vitamin D analogues, antimicrobial peptides, interleukin-1α and interleukin-1ß blockers and immunotherapy are some of the novel treatment options.


Subject(s)
Acne Vulgaris/drug therapy , Acne Vulgaris/pathology , Dermatologic Agents/administration & dosage , Sebaceous Glands/drug effects , Sebaceous Glands/pathology , Acne Vulgaris/metabolism , Administration, Topical , Humans , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/metabolism , Peroxisome Proliferator-Activated Receptors/antagonists & inhibitors , Peroxisome Proliferator-Activated Receptors/metabolism , Propionibacterium acnes/drug effects , Propionibacterium acnes/metabolism , Sebaceous Glands/metabolism , TOR Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/metabolism , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL